Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities
Net income (loss)	$ 4,020	$ (103,358)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation of property and equipment	41	67
Amortization of platform development and intangible assets	2,125	4,870
Amortization of debt discounts	31	536
Noncash and accrued interest		2,839
Loss on impairment of assets		40,589
Change in fair value of contingent consideration		313
Liquidated damages	75	76
Stock-based compensation	182	1,451
Deferred income taxes	31	31
Bad debt expense		670
Change in operating assets and liabilities:
Accounts receivable, net	(446)	12,029
Subscription acquisition costs		6,131
Prepayments and other current assets	75	(424)
Other long-term assets	4	(148)
Accounts payable	(1,332)	(102)
Accrued expenses and other	(188)	44,334
Unearned revenue	(1,329)	(11,665)
Subscription refund liability	232	18
Operating lease liabilities	141	(60)
Other long-term liabilities		(162)
Net cash provided by (used in) operating activities	3,662	(1,965)
Cash flows from investing activities
Capitalized platform development	(1,618)	(713)
Net cash used in investing activities	(1,618)	(713)
Cash flows from financing activities
Payment of Fexy put option		(2,263)
(Repayments) proceeds under line of credit, net borrowing		(19,609)
Proceeds from common stock private placement		12,000
Proceeds from Simplify loan		7,748
Repayment of Simplify loan	(3,500)
Payment of taxes from common stock withheld	(4)	(479)
Net cash used in financing activities	(3,504)	(2,603)
Net decrease in cash and cash equivalents	(1,460)	(5,281)
Cash and cash equivalents – beginning of year	4,362	9,284
Cash and cash equivalents – end of period	2,902	4,003
Supplemental disclosure of cash flow information
Cash paid for interest	2,973	964
Cash paid for income taxes		85
Noncash investing and financing activities
Reclassification of stock-based compensation to platform development	14	208
Repurchase of common stock for Fexy put option		$ 379